SEC Comment Letter for BRISTOL MYERS SQUIBB CO (BMY, BMYMP, CELG-RI) (CIK 0000014272) (BMY) — Feb 1, 2021

BRISTOL MYERS SQUIBB CO (BMY, BMYMP, CELG-RI) (CIK 0000014272)
Date: Feb. 1, 2021 · CIK: 0000014272 · Accession: 0000000000-21-001244

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 001-01136

Date

February 1, 2021

Author

Not clearly detected

Form

UPLOAD

Company

BRISTOL MYERS SQUIBB CO (BMY, BMYMP, CELG-RI) (CIK 0000014272)

Letter

United States securities and exchange commission logo February 1, 2021 Giovanni Caforio, M.D. Chairman of the Board and Chief Executive Officer Bristol-Myers Squibb Company 430 E. 29th Street, 14FL New York, NY 10016 Re:Bristol-Myers Squibb Company Form 10-K Filed February 24, 2020 File No. 001-01136 Dear Dr. Caforio: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Ms. Sandra Leung

Show Raw Text

United States securities and exchange commission logo
February 1, 2021
Giovanni Caforio, M.D.
Chairman of the Board and Chief Executive Officer
Bristol-Myers Squibb Company
430 E. 29th Street, 14FL
New York, NY 10016
Re:Bristol-Myers Squibb Company
Form 10-K
Filed February 24, 2020
File No. 001-01136
Dear Dr. Caforio:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Ms. Sandra Leung

SecProbe.io